Pharmaceutical News

RSS

International investigators fight against the negative campaign on benzodiazepines

In the current issue of Psychotherapy and Psychosomaticsthere is news about an international group of investigators who felt that benzodiazepines are getting unwarranted bad press, compared to other psychotropic drugs.

9 Dec 2018

Study: Drug reduces hot flash frequency, improves quality of life in breast cancer survivors

Research led by oncologists Roberto Leon-Ferre, M.D. and Charles Loprinzi, M.D. of Mayo Clinic has found that the drug oxybutynin helps to reduce the frequency and intensity of hot flashes in women who are unable to take hormone replacement therapy, including breast cancer survivors.

7 Dec 2018

High intensity statin treatment and adherence could save more lives

Thousands of heart attacks and deaths from cardiovascular disease could be prevented by patients taking higher doses of statins and taking the drugs as advised by doctors.

7 Dec 2018

VCU researchers test vaccine against opioid abuse

Virginia Commonwealth University researchers are testing a vaccine against opioid abuse developed by the Scripps Research Institute in California. The vaccine is meant to block the effects of heroin and fentanyl in patients with opioid use disorder.

7 Dec 2018

New study shows added benefit of ingenol mebutate for patients with actinic keratosis

Already in 2013, the German Institute for Quality and Efficiency in Health Care examined in an early benefit assessment whether ingenol mebutate offers greater benefit than the appropriate comparator therapy for patients with actinic keratosis.

7 Dec 2018

Deprescribing could help manage polypharmacy in older adults

Reducing the number of medications older adults use can have surprising benefits, according to research presented in a new issue of the journal Public Policy & Aging Report from The Gerontological Society of America.

6 Dec 2018

Statins are recommended far too often, study shows

Taking cholesterol-lowering drugs, or statins, as a preventive measure can reduce the risk of cardiovascular disease. A study by the University of Zurich now shows that this measure is recommended too often, as current guidelines fail to take into account the risks of side effects.

6 Dec 2018

CHOP celebrates EC approval of first and only gene therapy for patients with inherited retinal disease

Children's Hospital of Philadelphia celebrates a pivotal moment in medicine: approval by the European Commission of LUXTURNA (voretigene neparvovec), the first and only gene therapy for patients with an inherited retinal disease, last month.

6 Dec 2018

Heroin-assisted treatment can offer benefits, reduce harms

Providing supervised access to medical-grade heroin to people whose use continues after trying multiple traditional treatments has been successful in other countries, and should be piloted and studied in the United States, according to a new RAND Corporation study.

6 Dec 2018

Liraglutide drug associated with lower risk of cardiovascular events

Real world data from a large Nordic study shows that use of liraglutide, a drug for type 2 diabetes, is associated with a lower risk of myocardial infarction, stroke or cardiovascular death.

6 Dec 2018

Common antidepressant does not promote recovery after stroke, study finds

Stroke patients prescribed a common antidepressant show no improvement compared with those given a dummy drug, a study has found.

6 Dec 2018

Optimization of drug dose sizes can reduce pharmaceutical wastage

Pharmaceuticals are often dosed according to patient weight or body size which means that a dose must be individually measured. In a new study, lead author Anthony Hatswell of Delta Hat Limited and University College London in the UK, shows that by optimizing drug dose sizes available, wastage can be cut by as much as 50 percent.

6 Dec 2018

Cancer patients who take beta-blocker along with breast cancer drug have less heart damage

Breast cancer patients who take a heart drug at the same time as trastuzumab have less heart damage, according to a study presented today at EuroEcho-Imaging 2018.

5 Dec 2018

TARGET PharmaSolutions and Bristol Myers Squibb partner to advance IBD research

TARGET PharmaSolutions, Inc., a company focused on real-world evidence, is pleased to announce that Bristol Myers Squibb has entered into a strategic partnership for TARGET-IBD.

From Bristol-Myers Squibb 5 Dec 2018

Study investigates influence of different opioids on driving performance

Taking opioids for the treatment of pain has been associated with increased risks of crashing among drivers, but it is unknown whether this applies to all opioids or pertains to specific opioids only.

5 Dec 2018

Physician-scientists present updated efficacy data on CAR T-cell gene immunotherapy

Physician-scientists from Children's Hospital of Philadelphia presented updated efficacy and safety data on Kymriah--the first-ever U.S. Food and Drug Administration approved personalized CAR T-cell gene immunotherapy for aggressive blood cancers at the 60th American Society of Hematology annual meeting, as well as first-of-its-kind research on overcoming CAR T-cell resistance.

5 Dec 2018

Proton pump inhibitors in combination with oral anticoagulants reduce GI bleeding risk

A Vanderbilt University Medical Centerstudy published today in JAMA shows that patients already at higher risk for gastrointestinal bleeding gain a marked protection from this risk when they take a proton pump inhibitor in combination with an oral anticoagulant.

4 Dec 2018

Pharmaceutical News

International investigators fight against the negative campaign on benzodiazepines

Study: Drug reduces hot flash frequency, improves quality of life in breast cancer survivors

High intensity statin treatment and adherence could save more lives

VCU researchers test vaccine against opioid abuse

New study shows added benefit of ingenol mebutate for patients with actinic keratosis

Deprescribing could help manage polypharmacy in older adults

Statins are recommended far too often, study shows

CHOP celebrates EC approval of first and only gene therapy for patients with inherited retinal disease

Heroin-assisted treatment can offer benefits, reduce harms

Liraglutide drug associated with lower risk of cardiovascular events

Common antidepressant does not promote recovery after stroke, study finds

Optimization of drug dose sizes can reduce pharmaceutical wastage

Cancer patients who take beta-blocker along with breast cancer drug have less heart damage

TARGET PharmaSolutions and Bristol Myers Squibb partner to advance IBD research

Study investigates influence of different opioids on driving performance

Physician-scientists present updated efficacy data on CAR T-cell gene immunotherapy

Proton pump inhibitors in combination with oral anticoagulants reduce GI bleeding risk

Study finds omitted medicine to be the most common medication administration errors

Consumption of antibiotics for children varies widely from country to country, finds study

Oral drug used to treat blood clots in cancer patients appears to be safe and effective

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News